|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$35,002
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
$20,361
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
VHL
|
ZIA CP005803 08290
|
$52,954
|
$21,182
|
Caporaso, Neil
|
DCEG (NCI)
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,171
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
$16,123
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$31,690
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-19
|
$302,547
|
$45,382
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,540,531
|
$616,212
|
Linehan, W. Marston
|
CCR (NCI)
|
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-05
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
UM LAPs- U10 Grant
|
5U10CA180801-05
|
$763,048
|
$38,152
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
$15,575
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$7,586
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$183,408
|
$73,363
|
Merino, Maria
|
CCR (NCI)
|
|
|
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
|
1R35CA232097-01
|
$1,040,850
|
$260,213
|
CHAN, TIMOTHY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$648,792
|
$324,396
|
Vocke, Cathy
|
CCR (NCI)
|
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-03
|
$2,300,000
|
$2,300,000
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
|
5U01CA207532-02
|
$349,332
|
$349,332
|
DYKHUIZEN, EMILY
|
PURDUE UNIVERSITY
|
|
|
The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology
|
5R03CA212696-02
|
$74,750
|
$74,750
|
NANJUNDAN, MEERA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
The role of PLAG1 in Wilms tumor formation
|
5K08CA207849-02
|
$156,645
|
$156,645
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma
|
5F31CA213814-02
|
$44,524
|
$44,524
|
KUBALA, JACLYN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$380,989
|
$76,198
|
Lewandoski, Mark
|
CCR (NCI)
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$192,605
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$7,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$6,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$7,385
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$1,751
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
|
1R01CA216922-01A1
|
$426,489
|
$426,489
|
HENSKE, ELIZABETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
|
5R35CA197713-04
|
$767,523
|
$767,523
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
|
The function of Snf5, an epigenetic tumor suppressor
|
5R01CA113794-15
|
$369,757
|
$369,757
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
The effect of cancer-associated SETD2 mutations on transcription and chromatin organization
|
5F30CA192643-04
|
$40,541
|
$40,541
|
FAHEY, CATHERINE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$649,423
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
Targeting glycocalyx-mediated mechanisms of tumor metastasis
|
5R01CA204949-02
|
$453,981
|
$453,981
|
MUNN, LANCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
|
ZIA BC 011648
|
$549,081
|
$549,081
|
Srinivasan, Ramaprasad
|
CCR (NCI)
|
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-05
|
$7,938,884
|
$158,778
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-05S1
|
$670,913
|
$13,418
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
$172,512
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Studying metabolic stress signaling in renal cancer
|
5R01CA181196-05
|
$332,000
|
$332,000
|
GAN, BOYI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$659,879
|
$65,988
|
Yarchoan, Robert
|
CCR (NCI)
|
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$244,544
|
$146,727
|
Merino, Maria
|
CCR (NCI)
|
|
|
Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis
|
5R01CA184103-04
|
$370,575
|
$185,288
|
LIU, JUN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
|
5U10CA180882-05
|
$8,303,242
|
$166,065
|
MANDREKAR, SUMITHRA
|
MAYO CLINIC ROCHESTER
|
|
|
Stanford University NCTN- Network Lead Academic Site
|
5U10CA180816-05
|
$518,824
|
$12,971
|
WAKELEE, HEATHER
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$4,970
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$3,430
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$66,689
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$6,571
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
|
Spatiotemporal delivery of synergistic drug combinations to kidney cancer
|
1R01CA229772-01
|
$360,930
|
$360,930
|
SABBISETTI, VENKATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$553,334
|
$11,067
|
Trepel, Jane
|
CCR (NCI)
|
|
|
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
|
4R00CA197640-03
|
$249,000
|
$249,000
|
WANG, XIAOFENG
|
DARTMOUTH COLLEGE
|
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-03
|
$29,664
|
$29,664
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Total relevant funding to Kidney Cancer for this search: $51,102,165
|
